International Immunology, Vol. 15, No. 7, pp. 861-870,
July 2003
© 2003 Japanese Society for Immunology
LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function
1 Department of Bio-Research and Technologies and Proteins, and 2 Department of Inflammation and Immunomodulation Research, Eli Lilly & Co., Indianapolis, IN 46285, USA
The first two authors contributed equally to this work
Correspondence to: S. Na; E-mail: na_songqing{at}lilly.com or D. D. Yang; E-mail: yang_derek_di{at}lilly.com
Transmitting editor: R. Medzhitov
LIGHT, a newly identified member of the tumor necrosis factor (TNF) family, is expressed on activated T lymphocytes. To evaluate how LIGHT contributes to T cell functions, we generated LIGHT-deficient (LIGHT/) mice using gene targeting. Disruption of LIGHT significantly reduced CD8+ T cell-cycle progression, leading to reduced proliferation to anti-CD3, anti-CD3/anti-CD28 or allogeneic stimulation, whereas proliferation of CD4+ T cells remained unchanged. In contrast to the observed proliferative defects, isolated CD8+ T cells from LIGHT/ mice displayed normal cytotoxic effector function development when compared to wild-type CD8+ T cells. Underlying a potential mechanism of reduced CD8+ T cell proliferation, LIGHT/ CD8+ T cells displayed reduced surface levels of CD25 and a diminished ability to proliferate in response to exogenous IL-2. Furthermore, addition of IL-12 to LIGHT/ CD8+ T cell cultures could not ameliorate this proliferative defect. These results reveal a potential mechanism of action for LIGHT as a positive regulator of CD8+ T cell expansion, but not lytic effector function development.
Keywords: CD8+, effector function, LIGHT, T cell expansion
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Ronchetti, G. Nocentini, R. Bianchini, L. T. Krausz, G. Migliorati, and C. Riccardi Glucocorticoid-Induced TNFR-Related Protein Lowers the Threshold of CD28 Costimulation in CD8+ T Cells J. Immunol., November 1, 2007; 179(9): 5916 - 5926. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, A. S. Flies, D. B. Flies, G. Zhu, S. Anand, S. J. Flies, H. Xu, R. A. Anders, W. W. Hancock, L. Chen, et al. Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease Blood, May 1, 2007; 109(9): 4097 - 4104. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J Sedgmen, W. Dawicki, J. L Gommerman, K. Pfeffer, and T. H Watts LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice Int. Immunol., May 1, 2006; 18(5): 797 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mortarini, A. Scarito, D. Nonaka, M. Zanon, I. Bersani, E. Montaldi, E. Pennacchioli, R. Patuzzo, M. Santinami, and A. Anichini Constitutive Expression and Costimulatory Function of LIGHT/TNFSF14 on Human Melanoma Cells and Melanoma-Derived Microvesicles Cancer Res., April 15, 2005; 65(8): 3428 - 3436. [Abstract] [Full Text] [PDF] |
||||



